Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.
@article{Clerico2006CardiacEF, title={Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.}, author={Aldo Clerico and Fabio A. Recchia and Claudio Passino and Michele Emdin}, journal={American journal of physiology. Heart and circulatory physiology}, year={2006}, volume={290 1}, pages={ H17-29 } }
The discovery of cardiac natriuretic hormones required a profound revision of the concept of heart function. The heart should no longer be considered only as a pump but rather as a multifunctional and interactive organ that is part of a complex network and active component of the integrated systems of the body. In this review, we first consider the cross-talk between endocrine and contractile function of the heart. Then, based on the existing literature, we propose the hypothesis that cardiac…
263 Citations
[The heart as an endocrine organ].
- Medicine, BiologyOrvosi hetilap
- 2012
The discovery of cardiac hormone production significantly changed the evaluation of the function of the heart, which is rather regarded as a determining factor of the electrolyte and hemodynamic…
The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis.
- Medicine, BiologyClinica chimica acta; international journal of clinical chemistry
- 2009
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.
- Biology, MedicineAmerican journal of physiology. Heart and circulatory physiology
- 2011
The data supporting the hypothesis that the production and secretion of CNHs is the result of a complex integration among mechanical, chemical, hemodynamic, humoral, ischemic, and inflammatory inputs are discussed.
Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure.
- Biology, MedicinePharmacological research
- 2013
Natriuretic peptides and cardio-renal disease.
- Biology, MedicineInternational journal of cardiology
- 2014
The paradox of low BNP levels in obesity
- Biology, MedicineHeart Failure Reviews
- 2011
The aim of this review is to analyze in detail some possible pathophysiological mechanisms linking obesity and cardiac endocrine function, in order to try to explain the negative association…
Cardiovascular Pleiotropic Effects of Natriuretic Peptides
- Biology, MedicineInternational journal of molecular sciences
- 2019
The current evidence underlying the pleiotropic effects of NPs, underlying their importance in cardiovascular homeostasis, is discussed.
Atrial Natriuretic Peptide31–67: A Novel Therapeutic Factor for Cardiovascular Diseases
- Medicine, BiologyFrontiers in Physiology
- 2021
The use of proANP31–67 is evaluated as a new therapeutic strategy to repair end-organ damage secondary to hypertension, diabetes mellitus, renal diseases, obesity, heart failure, and other morbidities that can lead to impaired cardiac function and structure.
Thyroid, Heart Failure, and Neuroendocrine Activation
- Medicine, Biology
- 2020
Limited evidence suggests that TH supplementation may improve the neurohormonal status of HF patients with the NTI, and the need to search and treat primary thyroid disorders in HF patients is outlined.
Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.
- Biology, MedicinePharmacology & therapeutics
- 2014
212 References
The physiological and pathophysiological modulation of the endocrine function of the heart.
- Biology, MedicineCanadian journal of physiology and pharmacology
- 2001
The finding that circulating levels of BNP are selectively increased before and during overt cardiac allograft rejection episodes in human patients suggests that enhanced BNP plasma levels could form a basis for a noninvasive test for cardiac allogsraft rejection.
Mechanical and neuroendocrine regulation of the endocrine heart.
- Biology, MedicineCardiovascular research
- 1996
Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?
- Medicine, BiologyJournal of cardiac failure
- 1995
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.
- Medicine, BiologyJournal of the American College of Cardiology
- 1992
Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations.
- Biology, MedicineCurrent drug metabolism
- 2000
A markedly altered degradation and distribution of ANP in patients with cardiac failure who show a resistance to its natriuretic effects, even in those on the early stage of clinical disease, is demonstrated.
Vasopeptidase inhibitors: potential role in the treatment of heart failure.
- Biology, MedicineHeart failure monitor
- 2001
The combined inhibition of ACE and NEP, by attenuating excessive vasoconstriction and enhancing vasodilator substances, holds promise as a valuable option in heart failure treatment for the near future.
Vasopeptidase inhibitors: potential role in the treatment of heart failure.
- Biology, Medicine
- 2001
The combined inhibition of ACE and NEP, by attenuating excessive vasoconstriction and enhancing vasodilator substances, holds promise as a valuable option in heart failure treatment for the near future.
Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms.
- Biology, MedicineBasic research in cardiology
- 2004
This review will outline the structure, expression and vascular actions of natriuretic peptides and their endogenous receptors and highlight recent work that has revealed important interactions between the cyclic GMP producing particulate and soluble guanylate cyclases, thereby linking the cardiovascular actions of NPTs and nitric oxide and a role for CNP as an endothelium-derived hyperpolarising factor (EDHF).
The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects.
- Medicine, BiologyJournal of nephrology
- 1998
These studies suggest that the abundance of NPr-C in adipose tissue may play a significant role in explaining at least part of the sodium retention characteristic of obesity associated hypertension.